Monday, The FDA approved the Pfizer-BioNTech Covid-19 vaccine children aged 12-15 years, and the CDC’s Vaccination Committee should vote on how to use this generation Wednesday. This comes at a time when the epidemic is spreading beyond our borders, and has already caused a great deal of controversy over child immunizations in the United States while many adults in Asia, Latin America, and Africa remain vaccinated. This is similar to a useless discussion, which will not help adults or children.
Of course, it is true that children do not often die from Covid-19 (although some do die). Of course, it is true that many children are not hospitalized with Covid-19 (although many are, especially those with immunodeficiency or other complications). Older children send SARS-CoV-2 at the same rates as adults, and new information this week shows children counting 24 percent of all new infections in the US (from 2% in April 2020), probably due to the growth of our vaccination program in adults. The reality is that children will suffer from long-term consequences (called post-acute sequelae) of the disease, as a result of mild symptoms in a critical area. We know that very few people have Multisystem Inflammatory Syndrome in Children, which can be fatal. As with any Covid related topic, however, it is much more than just the number of illnesses and deaths. The impact on children and adolescents is well documented as they affect their learning and the emergence of women with children in the workplace. This is one of the biggest challenges we have ever faced.
As a working parent of three healthy children (one who received a vaccine, one who has just been approved, and one who has not yet qualified) with high incomes, access to the Internet, and local schools that follow the Covid-19 science guidelines, it is hard to imagine a vaccine my 15-year-old patient might be fine anywhere. Is that a valid question? Initially, for example, the Pfizer-BioNTech vaccine is not approved here in India, although this may change. We know that India needs oxygen, PPE, and other medical supplies and there are many American methods that can help and do this. The Lancet Covid-19 Commission India Task Force seeks a number of initiatives to address communicable diseases, among other things, Vaccine preparation of 5 million vaccines per day following those over the age of 45. He estimates that what is happening in India can achieve half of that goal, with greater potential if money and raw materials are available. This effort could bring long-term benefits to India over the short four-day supply of Pfizer-BioNTech (at 5 million doses per day) which could be given as 17 million to 15- 15 million elderly people in the US stop vaccinating.
Biden officials released a statement explaining the Covid-19 aid to India on April 28, stating $ 100 million in donations, including AstraZeneca vaccine ingredients. Also, US still holding stocks of the AstraZeneca vaccine, which may not be approved here, and these should go to countries that can be used here instead of sitting on the shelf. Many criticized what the supervisors said was not enough, especially considering the Covid-19 vaccine. These are the most important conversations that should be at the forefront of media coverage. The thoughtful thoughts on Twitter and writing stories from others who talk about public health are disturbing. Obviously children should be vaccinated. Obviously the US should help get a universal vaccine.
As a pediatrician, I have seen children repeatedly put at the end of the line when it comes to accepting life-saving HIV drugs. Instead, the most recent improvement in the work of pediatrics came at a time when a courageous doctor in Mississippi chose a method that did not follow guidelines. caring for the newborn, committed to efforts to prevent the spread of HIV. The story of “Son of Mississippi”It initiated many clinical trials and introduced new research methods for the treatment of HIV in children.